Health Catalyst
HCAT
108 hedge funds and large institutions have $675M invested in Health Catalyst in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 49 increasing their positions, 13 reducing their positions, and 13 closing their positions.
2,206% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $78K
277% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 13
169% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 13
23% more funds holding
Funds holding: 88 → 108 (+20)
4.99% more ownership
Funds ownership: 64.28% → 69.28% (+5%)
17% less capital invested
Capital invested by funds: $811M → $675M (-$136M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$38.9M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$31.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$31.2M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$28.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NVPX
Norwest Venture Partners XII
Palo Alto,
California
|
-$102M |
| 2 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$94.4M |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
-$23.8M |
| 4 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
-$18.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$11.4M |
HCAT Hedge Fund Activity: Q1 2020 in Review
108 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q1 2020, worth a combined $675M — down 17% from $811M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new HCAT positions and 13 closed out — a net gain of 22 holders — while 49 added to existing stakes and 13 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $38.9M. The largest seller was Norwest Venture Partners XII, exiting entirely with an estimated $102M sold.
- 108 institutional investors held Health Catalyst (HCAT) as of Q1 2020, up from 88 in Q4 2019.
- Funds reported $675M of Health Catalyst stock for Q1 2020, down 17% quarter-over-quarter.
- 35 funds opened new Health Catalyst positions in Q1 2020 and 13 closed out, a net change of +22 holders.
- The largest Health Catalyst buyer in Q1 2020 was Victory Capital Management, an estimated $38.9M added.
- The largest Health Catalyst seller in Q1 2020 was Norwest Venture Partners XII, an estimated $102M sold.
Based on aggregated 13F filings for Q1 2020.